TapewireFind a company

person · Reporting owner

INGRAM ROBERT ALEXANDER

Disclosed activity across 9 companies

Tapewire entity
16884
SEC CIK
0001219890

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BIOCRYST PHARMACEUTICALS INCBCRX · Entity 315DirectorFebruary 28, 2023March 02, 2023
Bausch Health Companies Inc.VRX · Entity 4363DirectorMarch 31, 2017April 04, 2017
G1 Therapeutics, Inc.GTHX · Entity 8741310% ownerMay 30, 2018June 01, 2018
LOWES COMPANIES INCLOW · Entity 2896DirectorMarch 31, 2011April 04, 2011
Novan, Inc.NOVN · Entity 111882DirectorJuly 28, 2020July 30, 2020
PhaseBio Pharmaceuticals IncPHAS · Entity 11330510% ownerOctober 22, 2018October 24, 2018
WOLFSPEED, INC.CREE · Entity 619DirectorOctober 17, 2018October 18, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BIOCRYST PHARMACEUTICALS INC

Report date February 28, 2023 · Filed March 02, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect100,198 Reported balance After 2023-02-28 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-02-28 · Grant · Acquired 2,259 · Balance 100,198

F1: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $20,000.

Filing footnotes · ownership attribution and instrument terms

F1: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $20,000.

Bausch Health Companies Inc.

Report date March 31, 2017 · Filed April 04, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, no par valueSEC Table I · non-derivativeDirect92,046 Reported balance After 2017-03-31 transaction · row 1
1 source row

Row 1 · 2017-03-31 · Grant · Acquired 2,120 · Balance 92,046

F1: Represents Restricted Share Units (RSUs) representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.

Filing footnotes · ownership attribution and instrument terms

F1: Represents Restricted Share Units (RSUs) representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee Footnotes3,279,421 Reported balance After 2018-05-30 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2018-05-30 · Sale · Disposed 758,290 · Balance 3,279,421

F1: Following the reported transaction, in which none of the reportable securities owned directly by Hatteras Venture Advisors V, LLC ("HVA V") were sold, 995 shares of the reportable securities are owned directly by HVA V. The securities directly held by HVA V are indirectly held by the individual managing members of HVA V (each, a "Managing Member" and collectively, the "Managing Members"). The Managing Members are John Crumpler, Clay Thorp, Christy Shaffer, Douglas Reed and Robert Ingram. The Managing Members may share voting and dispositive power over the securities directly held by HVA V. Each Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his or her pecuniary interest therein.

F2: Following the reported transaction, 3,067,962 shares of the reportable securities are owned directly by Hatteras Venture Partners IV SBIC, LP ("HVP IV"). Hatteras Venture Advisors IV SBIC, LLC ("HVA IV SBIC") is the general partner of HVP IV. The securities directly held by HVP IV are indirectly held by the individual managing members of HVA IV SBIC (each, a "GP Managing Member" and collectively, the "GP Managing Members"). The GP Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The GP Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each GP Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any GP Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.

F3: Following the reported transaction, in which none of the reportable securities owned directly by Hatteras NC Fund, LP ("Hatteras NC") were sold, 210,464 shares of the reportable securities are owned directly by Hatteras NC. Hatteras Venture Advisors IV, LLC ("HVA IV") is the general partner of Hatteras NC. The securities directly held by Hatteras NC are indirectly held by the individual managing members of HVA IV (each, a "HVA IV Managing Member"). The HVA IV Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The HVA IV Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each HVA IV Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any HVA IV Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his or her pecuniary interest therein.

Common StockSEC Table I · non-derivativeIndirectSee Footnotes3,237,711 Reported balance After 2018-05-30 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2018-05-30 · Sale · Disposed 41,710 · Balance 3,237,711

F1: Following the reported transaction, in which none of the reportable securities owned directly by Hatteras Venture Advisors V, LLC ("HVA V") were sold, 995 shares of the reportable securities are owned directly by HVA V. The securities directly held by HVA V are indirectly held by the individual managing members of HVA V (each, a "Managing Member" and collectively, the "Managing Members"). The Managing Members are John Crumpler, Clay Thorp, Christy Shaffer, Douglas Reed and Robert Ingram. The Managing Members may share voting and dispositive power over the securities directly held by HVA V. Each Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his or her pecuniary interest therein.

F4: Following the reported transaction, 168,754 shares of the reportable securities are owned directly by Hatteras NC.

F5: Following the reported transaction, in which none of the reportable securities owned directly by HVP IV were sold, 3,067,962 shares of the reportable securities are owned directly by HVP IV.

Filing footnotes · ownership attribution and instrument terms

F1: Following the reported transaction, in which none of the reportable securities owned directly by Hatteras Venture Advisors V, LLC ("HVA V") were sold, 995 shares of the reportable securities are owned directly by HVA V. The securities directly held by HVA V are indirectly held by the individual managing members of HVA V (each, a "Managing Member" and collectively, the "Managing Members"). The Managing Members are John Crumpler, Clay Thorp, Christy Shaffer, Douglas Reed and Robert Ingram. The Managing Members may share voting and dispositive power over the securities directly held by HVA V. Each Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his or her pecuniary interest therein.

F2: Following the reported transaction, 3,067,962 shares of the reportable securities are owned directly by Hatteras Venture Partners IV SBIC, LP ("HVP IV"). Hatteras Venture Advisors IV SBIC, LLC ("HVA IV SBIC") is the general partner of HVP IV. The securities directly held by HVP IV are indirectly held by the individual managing members of HVA IV SBIC (each, a "GP Managing Member" and collectively, the "GP Managing Members"). The GP Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The GP Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each GP Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any GP Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.

F3: Following the reported transaction, in which none of the reportable securities owned directly by Hatteras NC Fund, LP ("Hatteras NC") were sold, 210,464 shares of the reportable securities are owned directly by Hatteras NC. Hatteras Venture Advisors IV, LLC ("HVA IV") is the general partner of Hatteras NC. The securities directly held by Hatteras NC are indirectly held by the individual managing members of HVA IV (each, a "HVA IV Managing Member"). The HVA IV Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The HVA IV Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each HVA IV Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any HVA IV Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his or her pecuniary interest therein.

F4: Following the reported transaction, 168,754 shares of the reportable securities are owned directly by Hatteras NC.

F5: Following the reported transaction, in which none of the reportable securities owned directly by HVP IV were sold, 3,067,962 shares of the reportable securities are owned directly by HVP IV.

LOWES COMPANIES INC

Report date March 31, 2011 · Filed April 04, 2011

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible securityDirect32,429.879 Reported balance After 2011-03-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2011-03-31 · Grant · Acquired 709.421 · Balance 32,429.879

F1: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Novan, Inc.

Report date July 28, 2020 · Filed July 30, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.78 · Expires 2030-07-27Direct20,000 Reported balance After 2020-07-28 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2020-07-28 · Grant · Acquired 20,000 · Balance 20,000

F1: The option vests in four equal quarterly installments, with the first installment vesting on October 28, 2020.

Filing footnotes · ownership attribution and instrument terms

F1: The option vests in four equal quarterly installments, with the first installment vesting on October 28, 2020.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Hatteras Venture Partners I, LP52,690 Reported balance After 2018-10-22 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2018-10-22 · Conversion · Acquired 52,690 · Balance 52,690

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F2: Catalysta Ventures, LLC ("Catalysta") is under common control with Hatteras Venture Advisors III, LLC ("HVA III"). Catalysta is the general partner of Hatteras Venture Partners I, LP ("HVP I"). The securities held directly by HVP I are indirectly held by Catalysta, which may be deemed to share voting and dispositive power with regard to the securities directly held by HVP I. Catalysta disclaims beneficial ownership of the securities held by HVP I except to the extent of its pecuniary interest therein. The individual managers of Catalysta are Clay B. Thorp and John Crumpler (the "Managers"), who may be deemed to share voting and dispositive power with regard to the securities held directly by Catalysta and HVP I. The Managers disclaim beneficial ownership of the securities held by Catalysta and HVP I except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Common StockSEC Table I · non-derivativeIndirectBy Hatteras Venture Partners III, LP1,820,933 Last balance in matching sequence After 2018-10-22 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 2 · 2018-10-22 · Conversion · Acquired 1,683,420 · Balance 1,683,420

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Row 3 · 2018-10-22 · Purchase · Acquired 137,513 · Balance 1,820,933

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Common StockSEC Table I · non-derivativeIndirectBy Hatteras Venture Affiliates III, LP163,099 Last balance in matching sequence After 2018-10-22 transaction · row 5 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 4 · 2018-10-22 · Conversion · Acquired 150,612 · Balance 150,612

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Row 5 · 2018-10-22 · Purchase · Acquired 12,487 · Balance 163,099

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Common StockSEC Table I · non-derivativeIndirectBy Catalysta Ventures, LLC4,846 Reported balance After 2018-10-22 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 6 · 2018-10-22 · Conversion · Acquired 4,846 · Balance 4,846

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F2: Catalysta Ventures, LLC ("Catalysta") is under common control with Hatteras Venture Advisors III, LLC ("HVA III"). Catalysta is the general partner of Hatteras Venture Partners I, LP ("HVP I"). The securities held directly by HVP I are indirectly held by Catalysta, which may be deemed to share voting and dispositive power with regard to the securities directly held by HVP I. Catalysta disclaims beneficial ownership of the securities held by HVP I except to the extent of its pecuniary interest therein. The individual managers of Catalysta are Clay B. Thorp and John Crumpler (the "Managers"), who may be deemed to share voting and dispositive power with regard to the securities held directly by Catalysta and HVP I. The Managers disclaim beneficial ownership of the securities held by Catalysta and HVP I except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Common StockSEC Table I · non-derivativeIndirectBy Venture Capital Multiplier Fund416,481 Last balance in matching sequence After 2018-10-22 transaction · row 8 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 7 · 2018-10-22 · Conversion · Acquired 266,481 · Balance 266,481

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Row 8 · 2018-10-22 · Purchase · Acquired 150,000 · Balance 416,481

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Warrants to Purchase Series B Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.12IndirectBy Hatteras Venture Partners III, LP0 Reported balance After 2018-10-22 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2018-10-22 · Other · Disposed 19,061 · Balance 0

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F5: The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering.

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series B Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Partners III, LP1,045,222 Reported balance After 2018-10-22 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2018-10-22 · Other · Acquired 19,061 · Balance 1,045,222

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series B Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Partners III, LP1,044,764 Reported balance After 2018-10-22 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2018-10-22 · Sale · Disposed 458 · Balance 1,044,764

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series B Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Partners III, LP0 Reported balance After 2018-10-22 transaction · row 30 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 30 · 2018-10-22 · Conversion · Disposed 1,044,764 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Warrants to Purchase Series B Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.12IndirectBy Hatteras Venture Affiliates III, LP0 Reported balance After 2018-10-22 transaction · row 12 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 12 · 2018-10-22 · Other · Disposed 1,731 · Balance 0

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F5: The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering.

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series B Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Affiliates III, LP94,916 Reported balance After 2018-10-22 transaction · row 13 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 13 · 2018-10-22 · Other · Acquired 1,731 · Balance 94,916

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series B Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Affiliates III, LP94,874 Reported balance After 2018-10-22 transaction · row 14 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 14 · 2018-10-22 · Sale · Disposed 42 · Balance 94,874

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series B Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Affiliates III, LP0 Reported balance After 2018-10-22 transaction · row 31 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 31 · 2018-10-22 · Conversion · Disposed 94,874 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Warrants to Purchase Series C-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.12IndirectBy Hatteras Venture Partners III, LP0 Reported balance After 2018-10-22 transaction · row 15 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 15 · 2018-10-22 · Other · Disposed 47,458 · Balance 0

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F5: The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering.

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series C-1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Partners III, LP150,459 Reported balance After 2018-10-22 transaction · row 16 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 16 · 2018-10-22 · Other · Acquired 47,458 · Balance 150,459

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series C-1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Partners III, LP149,320 Reported balance After 2018-10-22 transaction · row 17 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 17 · 2018-10-22 · Sale · Disposed 1,139 · Balance 149,320

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series C-1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Partners III, LP0 Reported balance After 2018-10-22 transaction · row 32 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 32 · 2018-10-22 · Conversion · Disposed 149,320 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Warrants to Purchase Series C-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.12IndirectBy Hatteras Venture Affiliates III, LP0 Reported balance After 2018-10-22 transaction · row 18 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 18 · 2018-10-22 · Other · Disposed 4,309 · Balance 0

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F5: The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering.

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series C-1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Affiliates III, LP13,662 Reported balance After 2018-10-22 transaction · row 19 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 19 · 2018-10-22 · Other · Acquired 4,309 · Balance 13,662

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series C-1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Affiliates III, LP13,558 Reported balance After 2018-10-22 transaction · row 20 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 20 · 2018-10-22 · Sale · Disposed 104 · Balance 13,558

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series C-1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Affiliates III, LP0 Reported balance After 2018-10-22 transaction · row 33 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 33 · 2018-10-22 · Conversion · Disposed 13,558 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Warrants to Purchase Series C-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.12IndirectBy Venture Capital Multiplier Fund0 Reported balance After 2018-10-22 transaction · row 21 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 21 · 2018-10-22 · Other · Disposed 41,414 · Balance 0

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F5: The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering.

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series C-1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Venture Capital Multiplier Fund41,414 Reported balance After 2018-10-22 transaction · row 22 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 22 · 2018-10-22 · Other · Acquired 41,414 · Balance 41,414

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series C-1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Venture Capital Multiplier Fund40,420 Reported balance After 2018-10-22 transaction · row 23 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 23 · 2018-10-22 · Sale · Disposed 994 · Balance 40,420

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series C-1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Venture Capital Multiplier Fund0 Reported balance After 2018-10-22 transaction · row 34 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 34 · 2018-10-22 · Conversion · Disposed 40,420 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series 1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Partners I, LP0 Reported balance After 2018-10-22 transaction · row 24 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 24 · 2018-10-22 · Conversion · Disposed 52,690 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F2: Catalysta Ventures, LLC ("Catalysta") is under common control with Hatteras Venture Advisors III, LLC ("HVA III"). Catalysta is the general partner of Hatteras Venture Partners I, LP ("HVP I"). The securities held directly by HVP I are indirectly held by Catalysta, which may be deemed to share voting and dispositive power with regard to the securities directly held by HVP I. Catalysta disclaims beneficial ownership of the securities held by HVP I except to the extent of its pecuniary interest therein. The individual managers of Catalysta are Clay B. Thorp and John Crumpler (the "Managers"), who may be deemed to share voting and dispositive power with regard to the securities held directly by Catalysta and HVP I. The Managers disclaim beneficial ownership of the securities held by Catalysta and HVP I except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series 1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Partners III, LP0 Reported balance After 2018-10-22 transaction · row 25 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 25 · 2018-10-22 · Conversion · Disposed 42,530 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series 1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Affiliates III, LP0 Reported balance After 2018-10-22 transaction · row 26 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 26 · 2018-10-22 · Conversion · Disposed 3,862 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series 1 Preferred StockSEC Table II · derivative / convertible securityIndirectBy Catalysta Ventures, LLC0 Reported balance After 2018-10-22 transaction · row 27 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 27 · 2018-10-22 · Conversion · Disposed 4,846 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F2: Catalysta Ventures, LLC ("Catalysta") is under common control with Hatteras Venture Advisors III, LLC ("HVA III"). Catalysta is the general partner of Hatteras Venture Partners I, LP ("HVP I"). The securities held directly by HVP I are indirectly held by Catalysta, which may be deemed to share voting and dispositive power with regard to the securities directly held by HVP I. Catalysta disclaims beneficial ownership of the securities held by HVP I except to the extent of its pecuniary interest therein. The individual managers of Catalysta are Clay B. Thorp and John Crumpler (the "Managers"), who may be deemed to share voting and dispositive power with regard to the securities held directly by Catalysta and HVP I. The Managers disclaim beneficial ownership of the securities held by Catalysta and HVP I except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series AA Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Partners III, LP0 Reported balance After 2018-10-22 transaction · row 28 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 28 · 2018-10-22 · Conversion · Disposed 174,699 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series AA Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Affiliates III, LP0 Reported balance After 2018-10-22 transaction · row 29 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 29 · 2018-10-22 · Conversion · Disposed 13,609 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series D Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Partners III, LP0 Reported balance After 2018-10-22 transaction · row 35 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 35 · 2018-10-22 · Conversion · Disposed 272,107 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series D Preferred StockSEC Table II · derivative / convertible securityIndirectBy Hatteras Venture Affiliates III, LP0 Reported balance After 2018-10-22 transaction · row 36 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 36 · 2018-10-22 · Conversion · Disposed 24,709 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Series D Preferred StockSEC Table II · derivative / convertible securityIndirectBy Venture Capital Multiplier Fund0 Reported balance After 2018-10-22 transaction · row 37 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 37 · 2018-10-22 · Conversion · Disposed 226,061 · Balance 0

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.

F2: Catalysta Ventures, LLC ("Catalysta") is under common control with Hatteras Venture Advisors III, LLC ("HVA III"). Catalysta is the general partner of Hatteras Venture Partners I, LP ("HVP I"). The securities held directly by HVP I are indirectly held by Catalysta, which may be deemed to share voting and dispositive power with regard to the securities directly held by HVP I. Catalysta disclaims beneficial ownership of the securities held by HVP I except to the extent of its pecuniary interest therein. The individual managers of Catalysta are Clay B. Thorp and John Crumpler (the "Managers"), who may be deemed to share voting and dispositive power with regard to the securities held directly by Catalysta and HVP I. The Managers disclaim beneficial ownership of the securities held by Catalysta and HVP I except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

F3: HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.

F4: Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.

F5: The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering.

WOLFSPEED, INC.

Report date October 17, 2018 · Filed October 18, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
COMMON STOCKSEC Table I · non-derivativeDirect77,710 Reported balance After 2018-10-17 transaction · row 1
1 source row

Row 1 · 2018-10-17 · Grant · Acquired 760 · Balance 77,710

F1: Represents shares of Common Stock credited to the Reporting Person's 2018 deferral account under the Cree, Inc. Stock Compensation and Deferral Program, issuable following the Reporting Person's Separation of Service from Cree.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of Common Stock credited to the Reporting Person's 2018 deferral account under the Cree, Inc. Stock Compensation and Deferral Program, issuable following the Reporting Person's Separation of Service from Cree.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Black Diamond Therapeutics, Inc.

Report date December 16, 2022 · Filed December 20, 2022

Section 16 reporting ended · disclosed 2022-12-20. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect42,854 Reported balance After 2022-12-16 transaction · row 1
1 source row

Row 1 · 2022-12-16 · Grant · Acquired 9,375 · Balance 42,854

F1: These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.

F2: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 15, 2022.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.

F2: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 15, 2022.

Section 16 reporting ended · disclosed 2017-01-19. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee Footnote2,060,514 Last balance in matching sequence After 2017-01-19 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 1 · 2017-01-17 · Sale · Disposed 9,806 · Balance 2,080,364

F1: This transaction was executed in multiple trades at prices ranging from $8.68 to $9.22. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: The reportable securities are owned directly by Hatteras Venture Partners IV SBIC, LP ("HVP IV"). Hatteras Venture Advisors IV SBIC, LLC is the general partner of HVP IV (the "GP"). The securities directly held by HVP IV are indirectly held by the individual managing members of GP (each, a "GP Managing Member" and collectively, the "GP Managing Members"). The GP Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The GP Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each GP Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any GP Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.

Row 2 · 2017-01-18 · Sale · Disposed 12,258 · Balance 2,068,106

F3: This transaction was executed in multiple trades at prices ranging from $8.42 to $8.79. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: The reportable securities are owned directly by Hatteras Venture Partners IV SBIC, LP ("HVP IV"). Hatteras Venture Advisors IV SBIC, LLC is the general partner of HVP IV (the "GP"). The securities directly held by HVP IV are indirectly held by the individual managing members of GP (each, a "GP Managing Member" and collectively, the "GP Managing Members"). The GP Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The GP Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each GP Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any GP Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.

Row 3 · 2017-01-19 · Sale · Disposed 7,592 · Balance 2,060,514

F4: This transaction was executed in multiple trades at prices ranging from $8.01 to $8.65. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: The reportable securities are owned directly by Hatteras Venture Partners IV SBIC, LP ("HVP IV"). Hatteras Venture Advisors IV SBIC, LLC is the general partner of HVP IV (the "GP"). The securities directly held by HVP IV are indirectly held by the individual managing members of GP (each, a "GP Managing Member" and collectively, the "GP Managing Members"). The GP Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The GP Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each GP Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any GP Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was executed in multiple trades at prices ranging from $8.68 to $9.22. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: The reportable securities are owned directly by Hatteras Venture Partners IV SBIC, LP ("HVP IV"). Hatteras Venture Advisors IV SBIC, LLC is the general partner of HVP IV (the "GP"). The securities directly held by HVP IV are indirectly held by the individual managing members of GP (each, a "GP Managing Member" and collectively, the "GP Managing Members"). The GP Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The GP Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each GP Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any GP Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.

F3: This transaction was executed in multiple trades at prices ranging from $8.42 to $8.79. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F4: This transaction was executed in multiple trades at prices ranging from $8.01 to $8.65. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2008 Filed Jul 1, 2008 19:44 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 903.614 $20.75 $18,749.99
Disclosure

SEC source: 0000060667-08-000101 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,814.744

Underlying: Common Stock · 903.614 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
May 30, 2008 Filed Jun 2, 2008 19:16 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantDeferred Stock Units · Derivative 4,800 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000060667-08-000082 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,387.919

Underlying: Common Stock · 4,800 shares

Expires not disclosed

F1 · derivative.exercise_date: All Deferred Stock Units are immediately one hundred percent (100%) vested. The Company will issue one share of common stock in exchange for each Deferred Stock Unit upon termination of the holder's service as a member of the Board of Directors of the Company.

F1 · derivative.expiration_date: All Deferred Stock Units are immediately one hundred percent (100%) vested. The Company will issue one share of common stock in exchange for each Deferred Stock Unit upon termination of the holder's service as a member of the Board of Directors of the Company.

Read SEC document
May 21, 2008 Filed May 22, 2008 14:54 UTC LOWES COMPANIES INC LOW · Entity 2896 Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 8,000 $0.00 Strike: $17.96 $0.00
Disclosure

SEC source: 0000060667-08-000071 · edgardoc.xml · derivative · entry 6

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2008-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2008 Filed May 22, 2008 14:54 UTC LOWES COMPANIES INC LOW · Entity 2896 SaleCommon Stock 400 $23.92 $9,568.00
Disclosure

SEC source: 0000060667-08-000071 · edgardoc.xml · nonDerivative · entry 5

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
May 21, 2008 Filed May 22, 2008 14:54 UTC LOWES COMPANIES INC LOW · Entity 2896 SaleCommon Stock 2,700 $23.93 $64,611.00
Disclosure

SEC source: 0000060667-08-000071 · edgardoc.xml · nonDerivative · entry 4

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

Read SEC document
May 21, 2008 Filed May 22, 2008 14:54 UTC LOWES COMPANIES INC LOW · Entity 2896 SaleCommon Stock 1,000 $23.94 $23,940.00
Disclosure

SEC source: 0000060667-08-000071 · edgardoc.xml · nonDerivative · entry 3

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,100

Read SEC document
May 21, 2008 Filed May 22, 2008 14:54 UTC LOWES COMPANIES INC LOW · Entity 2896 SaleCommon Stock 3,900 $23.94 $93,366.39
Disclosure

SEC source: 0000060667-08-000071 · edgardoc.xml · nonDerivative · entry 2

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,100

Read SEC document
May 21, 2008 Filed May 22, 2008 14:54 UTC LOWES COMPANIES INC LOW · Entity 2896 Exercise / conversionCommon Stock 8,000 $17.96 $143,640.00
Disclosure

SEC source: 0000060667-08-000071 · edgardoc.xml · nonDerivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2008 Filed Apr 1, 2008 18:35 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 817.35 $22.94 $18,750.01
Disclosure

SEC source: 0000060667-08-000066 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,847.645

Underlying: Common Stock · 817.35 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
December 31, 2007 Filed Jan 2, 2008 19:10 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 828.912 $22.62 $18,749.99
Disclosure

SEC source: 0000060667-08-000004 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,969.852

Underlying: Common Stock · 828.912 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
September 30, 2007 Filed Oct 1, 2007 21:05 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 669.165 $28.02 $18,750.00
Disclosure

SEC source: 0000060667-07-000117 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,082.563

Underlying: Common Stock · 669.165 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
June 30, 2007 Filed Jul 2, 2007 20:45 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 610.948 $30.69 $18,749.99
Disclosure

SEC source: 0000060667-07-000090 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,361.804

Underlying: Common Stock · 610.948 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
May 25, 2007 Filed May 29, 2007 20:19 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantDeferred Stock Units · Derivative 3,600 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000060667-07-000069 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,455.702

Underlying: Common Stock · 3,600 shares

Expires not disclosed

F1 · derivative.exercise_date: All Deferred Stock Units are immediately one hundred percent (100%) vested. The Company will issue one share of common stock in exchange for each Deferred Stock Unit upon termination of the holder's service as a member of the Board of Directors of the Company.

F1 · derivative.expiration_date: All Deferred Stock Units are immediately one hundred percent (100%) vested. The Company will issue one share of common stock in exchange for each Deferred Stock Unit upon termination of the holder's service as a member of the Board of Directors of the Company.

Read SEC document
March 31, 2007 Filed Apr 2, 2007 19:38 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 595.427 $31.49 $18,750.00
Disclosure

SEC source: 0000060667-07-000051 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,721.824

Underlying: Common Stock · 595.427 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
December 31, 2006 Filed Jan 3, 2007 21:59 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 601.926 $31.15 $18,749.99
Disclosure

SEC source: 0000060667-07-000004 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,101.425

Underlying: Common Stock · 601.926 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
September 30, 2006 Filed Oct 2, 2006 21:26 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 668.211 $28.06 $18,750.00
Disclosure

SEC source: 0000060667-06-000143 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 668.211

Underlying: Common Stock · 668.211 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
June 30, 2006 Filed Jun 30, 2006 21:12 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 309.049 $60.67 $18,750.00
Disclosure

SEC source: 0000060667-06-000122 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,888.076

Underlying: Common Stock · 309.049 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
May 25, 2006 Filed May 26, 2006 19:49 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantDeferred Stock Units · Derivative 1,900 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000060667-06-000086 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,405.74

Underlying: Common Stock · 1,900 shares

Expires not disclosed

F1 · derivative.exercise_date: All Deferred Stock Units are immediately one hundred percent (100%) vested. The Company will issue one share of common stock in exchange for each Deferred Stock Unit upon termination of the holder's service as a member of the Board of Directors of the Company.

F1 · derivative.expiration_date: All Deferred Stock Units are immediately one hundred percent (100%) vested. The Company will issue one share of common stock in exchange for each Deferred Stock Unit upon termination of the holder's service as a member of the Board of Directors of the Company.

Read SEC document
March 31, 2006 Filed Apr 4, 2006 15:42 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 290.968 $64.44 $18,749.98
Disclosure

SEC source: 0000060667-06-000071 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,571.786

Underlying: Common Stock · 290.968 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
December 31, 2005 Filed Jan 3, 2006 19:19 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 281.278 $66.66 $18,749.99
Disclosure

SEC source: 0000060667-06-000002 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,274.017

Underlying: Common Stock · 281.278 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
September 30, 2005 Filed Oct 4, 2005 15:51 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 291.149 $64.40 $18,750.00
Disclosure

SEC source: 0000060667-05-000254 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,985.546

Underlying: Common Stock · 291.149 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
June 30, 2005 Filed Jul 5, 2005 15:36 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 322.054 $58.22 $18,749.98
Disclosure

SEC source: 0000060667-05-000173 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,688.407

Underlying: Common Stock · 322.054 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
May 27, 2005 Filed May 31, 2005 17:17 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantCommon Stock 1,500 $0.00 $0.00
Disclosure

SEC source: 0000060667-05-000127 · edgardoc.xml · nonDerivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Read SEC document
March 31, 2005 Filed Apr 1, 2005 20:54 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 328.429 $57.09 Strike: $0.00 $18,750.01
Disclosure

SEC source: 0000060667-05-000090 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,361.435

Underlying: Common Stock · 328.429 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
December 31, 2004 Filed Jan 18, 2005 17:37 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 325.577 $57.59 Strike: $0.00 $18,749.98
Disclosure

SEC source: 0000060667-05-000002 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,028.693

Underlying: Common Stock · 325.577 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
September 30, 2004 Filed Oct 1, 2004 18:04 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 344.986 $54.35 Strike: $0.00 $18,749.99
Disclosure

SEC source: 0000060667-04-000299 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,699.086

Underlying: Common Stock · 344.986 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

Read SEC document
June 30, 2004 Filed Jul 2, 2004 21:21 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 356.803 $52.55 $18,750.00
Disclosure

SEC source: 0000060667-04-000258 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,346.811

Underlying: Common Stock · 356.803 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_price: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F2 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

Read SEC document
May 28, 2004 Filed Jun 1, 2004 20:40 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantNon-Qualified Stock Option (right to buy) · Derivative 4,000 $0.00 Strike: $53.57 $0.00
Disclosure

SEC source: 0000060667-04-000226 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2011-05-27

F1 · derivative.exercise_date: The option will vest in three annual installments commencing on May 15, 2004.

Read SEC document
March 31, 2004 Filed Apr 2, 2004 23:37 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 334.046 $56.13 $18,750.00
Disclosure

SEC source: 0000060667-04-000180 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,990.008

Underlying: Common Stock · 334.046 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

Read SEC document
January 30, 2004 Filed Feb 20, 2004 21:41 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 2.619 $0.00 $0.00
Disclosure

SEC source: 0000060667-04-000039 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,655.962

Underlying: Common Stock · 2.619 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

Read SEC document
December 31, 2003 Filed Jan 5, 2004 20:40 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 338.509 $0.00 $0.00
Disclosure

SEC source: 0000060667-04-000017 · edgardoc.xml · derivative · entry 2

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,653.343

Underlying: Common Stock · 338.509 shares

Expires not disclosed

F4 · derivative.exercise_price: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F5 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F6 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

Read SEC document
October 31, 2003 Filed Jan 5, 2004 20:40 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 2.176 $0.00 $0.00
Disclosure

SEC source: 0000060667-04-000017 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,314.834

Underlying: Common Stock · 2.176 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

Read SEC document
September 30, 2003 Filed Oct 2, 2003 19:57 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 361.272 $0.00 $0.00
Disclosure

SEC source: 0000060667-03-000195 · edgardoc.xml · derivative · entry 2

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,312.582

Underlying: Common Stock · 361.272 shares

Expires not disclosed

F4 · derivative.exercise_price: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F5 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F6 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

Read SEC document
August 01, 2003 Filed Oct 2, 2003 19:57 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 2 $0.00 $0.00
Disclosure

SEC source: 0000060667-03-000195 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,951.31

Underlying: Common Stock · 2 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the credit of dividends to the Reporting Person's deferred stock account under the Lowe's Deferred Compensation Program.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

F3 · derivative.expiration_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's.

Read SEC document
June 30, 2003 Filed Jul 1, 2003 20:42 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 437 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000060667-03-000106 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · 437 shares

Expires 1988-08-08

F1 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's. This footnote should also correspond to the Expiration Date column.

Read SEC document
June 30, 2003 Filed Jul 2, 2003 19:06 UTC Amendment LOWES COMPANIES INC LOW · Entity 2896 GrantPhantom Stock · Derivative 436.554 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000060667-03-000110 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,949.31

Underlying: Common Stock · 436.554 shares

Expires 1988-08-08

F1 · shares: This amendment is being filed to correct clerical errors in Table II Columns 5, 7 and 9 of the original filing.This footnote also corrresponds to Columns 7 and 9.

F2 · derivative.exercise_date: The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of Lowe's. This footnote should also correspond to the Expiration Date column.

Read SEC document
May 30, 2003 Filed Jun 3, 2003 13:16 UTC LOWES COMPANIES INC LOW · Entity 2896 GrantNon-Qualified Stock Option (right to buy) · Derivative 4,000 $0.00 Strike: $42.26 $0.00
Disclosure

SEC source: 0000060667-03-000041 · edgardoc.xml · derivative · entry 1

INGRAM ROBERT A · CIK 0001219890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · 4,000 shares

Expires 2010-05-30

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.